These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 8465635

  • 21. Urine cytology of primary and secondary urinary bladder adenocarcinoma.
    Bardales RH, Pitman MB, Stanley MW, Korourian S, Suhrland MJ.
    Cancer; 1998 Dec 25; 84(6):335-43. PubMed ID: 9915134
    [Abstract] [Full Text] [Related]

  • 22. Microsatellite analysis of voided-urine samples for surveillance of low-grade non-muscle-invasive urothelial carcinoma: feasibility and clinical utility in a prospective multicenter study (Cost-Effectiveness of Follow-Up of Urinary Bladder Cancer trial [CEFUB]).
    van der Aa MN, Zwarthoff EC, Steyerberg EW, Boogaard MW, Nijsen Y, van der Keur KA, van Exsel AJ, Kirkels WJ, Bangma C, van der Kwast TH.
    Eur Urol; 2009 Mar 25; 55(3):659-67. PubMed ID: 18501499
    [Abstract] [Full Text] [Related]

  • 23. Comparison of NMP22 BladderChek test and urine cytology for the detection of recurrent bladder cancer.
    Kumar A, Kumar R, Gupta NP.
    Jpn J Clin Oncol; 2006 Mar 25; 36(3):172-5. PubMed ID: 16520358
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Urinary cytology in the detection of bladder tumours. Influence of concomitant urothelial atypia.
    Harving N, Petersen SE, Melsen F, Wolf H.
    Scand J Urol Nephrol Suppl; 1989 Mar 25; 125():127-31. PubMed ID: 2633311
    [Abstract] [Full Text] [Related]

  • 27. Urinary CYFRA 21.1 is not a useful marker for the detection of recurrences in the follow-up of superficial bladder cancer.
    Fernandez-Gomez J, Rodríguez-Martínez JJ, Barmadah SE, García Rodríguez J, Allende DM, Jalon A, Gonzalez R, Alvarez-Múgica M.
    Eur Urol; 2007 May 25; 51(5):1267-74. PubMed ID: 17207912
    [Abstract] [Full Text] [Related]

  • 28. The clinicopathologic correlates of cellular atypia in urinary cytology of ileal neobladders.
    Cimino-Mathews A, Ali SZ.
    Acta Cytol; 2011 May 25; 55(5):449-54. PubMed ID: 21986173
    [Abstract] [Full Text] [Related]

  • 29. Combined morphologic and fluorescence in situ hybridization analysis of voided urine samples for the detection and follow-up of bladder cancer in patients with benign urine cytology.
    Daniely M, Rona R, Kaplan T, Olsfanger S, Elboim L, Freiberger A, Lew S, Leibovitch I.
    Cancer; 2007 Dec 25; 111(6):517-24. PubMed ID: 17963263
    [Abstract] [Full Text] [Related]

  • 30. [Usefulness of P53 oncoprotein in urinary wash cytology: experience in patients with superficial bladder carcinoma].
    Moreno Sierra J, Luengo Alpuente S, López García-Asenjo J, Redondo González E, Blanco Jiménez E, Fernández Pérez C, Silmi Moyano A, Resel Estévez L.
    Arch Esp Urol; 1999 Nov 25; 52(9):943-54. PubMed ID: 10633962
    [Abstract] [Full Text] [Related]

  • 31. The dilemma of suspicious urine cytology in patients being followed for bladder cancer.
    Raitanen MP, Aine R, Kylmälä T, Kallio J, Liukkonen T, Tammela T, Finnbladder Group.
    Ann Chir Gynaecol; 2001 Nov 25; 90(4):256-9. PubMed ID: 11820413
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. [The BTA stat test in the follow-up for bladder cancer].
    Gutiérrez Baños JL, Martín García B, de Diego Rodríguez E, Hernández Rodríguez R, Portillo Martín JA, Correas Gómez MA, del Valle Schaan JI, Roca Edreira A, Rado Velázquez MA.
    Arch Esp Urol; 1999 Oct 25; 52(8):856-61. PubMed ID: 10589117
    [Abstract] [Full Text] [Related]

  • 36. [Cytology by lavage in the follow-up of bladder neoplasms].
    Salinas Sánchez AS, Sola Pérez J, Ortuño Pacheco G, Server Falgas G.
    Arch Esp Urol; 1989 Oct 25; 42(6):523-31. PubMed ID: 2817982
    [Abstract] [Full Text] [Related]

  • 37. Urinary levels of urokinase-type plasminogen activator and its receptor in the detection of bladder carcinoma.
    Casella R, Shariat SF, Monoski MA, Lerner SP.
    Cancer; 2002 Dec 15; 95(12):2494-9. PubMed ID: 12467062
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.